569 related articles for article (PubMed ID: 16294904)
1. TCP and NTCP in preclinical and clinical research in Europe.
Baumann M; Petersen C; Krause M
Rays; 2005; 30(2):121-6. PubMed ID: 16294904
[TBL] [Abstract][Full Text] [Related]
2. TCP and NTCP: a basic introduction.
Baumann M; Petersen C
Rays; 2005; 30(2):99-104. PubMed ID: 16294901
[TBL] [Abstract][Full Text] [Related]
3. Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer.
Grégoire V
Rays; 2005; 30(2):105-8. PubMed ID: 16294902
[TBL] [Abstract][Full Text] [Related]
4. A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy.
Gay HA; Niemierko A
Phys Med; 2007 Dec; 23(3-4):115-25. PubMed ID: 17825595
[TBL] [Abstract][Full Text] [Related]
5. Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships.
El Naqa I; Suneja G; Lindsay PE; Hope AJ; Alaly JR; Vicic M; Bradley JD; Apte A; Deasy JO
Phys Med Biol; 2006 Nov; 51(22):5719-35. PubMed ID: 17068361
[TBL] [Abstract][Full Text] [Related]
6. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain.
Marcu LG
Cancer Treat Rev; 2010 Dec; 36(8):606-14. PubMed ID: 20494524
[TBL] [Abstract][Full Text] [Related]
7. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.
Keall PJ; Webb S
Phys Med Biol; 2007 Jan; 52(1):291-302. PubMed ID: 17183142
[TBL] [Abstract][Full Text] [Related]
8. Biological, physical factors in clinical assessment of outcome of cancer therapy.
Perez CA
Rays; 2005; 30(2):85-98. PubMed ID: 16294900
[TBL] [Abstract][Full Text] [Related]
9. Dose painting and theragnostic imaging: towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology.
Bentzen SM
Cancer Treat Res; 2008; 139():41-62. PubMed ID: 18236711
[No Abstract] [Full Text] [Related]
10. EUCLID: an outcome analysis tool for high-dimensional clinical studies.
Gayou O; Parda DS; Miften M
Phys Med Biol; 2007 Mar; 52(6):1705-19. PubMed ID: 17327657
[TBL] [Abstract][Full Text] [Related]
11. A method to visualize the uncertainty of the prediction of radiobiological models.
Zhang L; Hub M; Thieke C; Floca RO; Karger CP
Phys Med; 2013 Sep; 29(5):556-61. PubMed ID: 23260766
[TBL] [Abstract][Full Text] [Related]
12. Clinical heterogeneity and tumor control probability.
Eisbruch A
Acta Oncol; 2010 Nov; 49(8):1385-7. PubMed ID: 20500028
[TBL] [Abstract][Full Text] [Related]
13. [The determination of the optimal irradiation dose in the tumor tissue-normal body tissues system].
Klepper LIa
Med Tekh; 1997; (4):18-21. PubMed ID: 9379858
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
15. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.
Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197
[TBL] [Abstract][Full Text] [Related]
16. [The interactive determination of the mathematical model parameters for the planning of the radiation therapy of malignant tumors. 2. A method of adjusting the mathematical model parameters for calculating the tolerance doses and probabilities of the occurrence of radiation complications in body organs and tissues].
Klepper LIa
Med Tekh; 2000; (5):36-40. PubMed ID: 11076364
[TBL] [Abstract][Full Text] [Related]
17. Evaluating advanced technologies in radiation oncology: when and how should randomized trials be done?
Sanguineti G; DeWeese TL
Oncology (Williston Park); 2009 Apr; 23(4):390, 393. PubMed ID: 19476271
[No Abstract] [Full Text] [Related]
18. CalcNTCP: a simple tool for computation of normal tissue complication probability (NTCP) associated with cancer radiotherapy.
Khan HA
Int J Radiat Biol; 2007 Oct; 83(10):717-20. PubMed ID: 17729166
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy adapted to spatial and temporal variability in tumor hypoxia.
Søvik A; Malinen E; Skogmo HK; Bentzen SM; Bruland OS; Olsen DR
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1496-504. PubMed ID: 17674980
[TBL] [Abstract][Full Text] [Related]
20. Clinical trials and radiation oncology technologies.
Michalski JM; Bosch WR; Purdy JA
Oncology (Williston Park); 2009 Apr; 23(4):386, 389. PubMed ID: 19476270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
